MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

10 Nov 2023 Evaluate
The sales is pegged at Rs. 993.12 millions for the September 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 1107.19 millions during the year-ago period.The Company to register a -46.33%  fall in the net profit for the quarter ended September 2023.Operating profit for the quarter ended September 2023 decreased to 107.90 millions as compared to 189.61 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 993.12 1107.19 -10.30 1771.75 1816.73 -2.48 3796.36 4058.42 -6.46
Other Income 39.48 30.32 30.21 76.34 60.44 26.31 145.42 153.83 -5.47
PBIDT 107.90 189.61 -43.09 216.34 253.03 -14.50 589.34 948.56 -37.87
Interest 0.30 0.20 50.00 0.54 0.44 22.73 0.77 4.85 -84.12
PBDT 107.60 189.41 -43.19 215.80 252.59 -14.57 588.57 943.71 -37.63
Depreciation 15.54 15.21 2.17 29.46 25.88 13.83 52.12 37.95 37.34
PBT 92.06 174.20 -47.15 186.34 226.71 -17.81 536.45 905.76 -40.77
TAX 23.56 46.56 -49.40 47.71 62.43 -23.58 138.11 233.88 -40.95
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 68.50 127.64 -46.33 138.63 164.28 -15.61 398.34 671.88 -40.71
Equity 28.91 29.23 -1.09 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 10.86 17.13 -36.56 12.21 13.93 -12.33 15.52 23.37 -33.58
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..